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A B S T R A C T
A case of melioidosis with a mycotic aneurysm is reported. The blood and tissue isolates were identiﬁed
as three different species of Burkholderia using the automated identiﬁcation systems, VITEK 2 and
matrix-assisted laser desorption/ionization time-of-ﬂight mass spectrometry (MALDI-TOF MS). The
isolate was conﬁrmed as Burkholderia pseudomallei by 16S rRNA sequencing. The typical features of the
Gram staining of colonies and 16S rRNA sequencing can be useful to identify B. pseudomallei.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Melioidosis is a tropical disease found in Australia, Southeast
Asia, and South Asia. It is caused by the Gram-negative bacillus
Burkholderia pseudomallei and has a mortality rate of up to 50%.1
Only six imported cases have been reported in Korea over the last
10 years; the clinical manifestations of the reported cases were
pneumonia and prostate or neck abscesses.2 The ﬁrst melioidosis
case in Korea presenting as a mycotic aneurysm is reported here;
identiﬁcation was by culture, automated identiﬁcation systems,
and 16S rRNA sequencing.
2. Case report
A 64-year-old man who lived in Busan, Korea, presented with
fever accompanied by dysuria. The day before the dysuria
occurred, he had returned from Thailand, where he had stayed§ H. R. Jang and C. W. Lee are co-ﬁrst authors and contributed equally to this work.
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).for 6 days. His medical history included IgA nephropathy, gout, and
hypertension. He visited a local urology clinic and underwent
prostate abscess drainage and antibiotic treatment. After 3 weeks,
he was transferred to the urology clinic in our hospital due to the
recurrence of the prostate abscess. He underwent further prostate
abscess drainage. After a month, he re-visited the emergency room
suffering fever and dyspnea. His body temperature was 38.7 8C, his
blood pressure was 130/80 mmHg, and his heart rate was 119 beats
per min. On examination, lung sounds were clear and his heart beat
was regular without murmur. Laboratory tests showed a white
blood cell count of 6.57  109 cells/l (neutrophils 85.4%),
hemoglobin level of 10.1 g/dl, and an elevated level of C-reactive
protein at 20.18 mg/dl. Computed tomography (CT) angiography
showed multifocal aneurysms in the aortic arch of the thoracic
aorta and pseudoaneurysm in the abdominal aorta and the inferior
area of the superior mesenteric artery (Figure 1). He was treated
with piperacillin/tazobactam and vancomycin. Because the my-
cotic aneurysm was highly likely to rupture, he underwent total
thoracic aortic arch replacement surgery. During the operation, the
mycotic aneurysm did in fact rupture. Analysis of the blood and
tissue cultures showed Gram-negative bacilli and bipolar staining
with a ‘safety pin’ appearance. Colonies were cream-colored andciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Figure 1. Computed tomography scans of the patient’s aorta. (A) Protruding lesion
on the aortic arch with a contrast ﬁlling defect suggesting mycotic aneurysm,
2.4  6.0 cm. (B) Infrarenal type abdominal aortic aneurysm, 1.8  2.8 cm.
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VITEK 2 system (bioMe´rieux, Inc., Hazelwood, MO, USA), B.
pseudomallei was identiﬁed from the blood isolate and Burkholderia
cepacia from the tissue isolate. The blood isolate was identiﬁed as
Burkholderia thailandensis with a score value of 1.901 by matrix-
assisted laser desorption/ionization time-of-ﬂight mass spectrom-
etry (MALDI-TOF MS; Bruker, Billerica, MA, USA).
To conﬁrm the identity of the blood isolate, 16S ribosomal RNA
(rRNA) sequencing analysis was performed. The bacterial genomic
DNA was extracted using InstaGene Matrix (Bio-Rad Laboratories,
Hercules, CA, USA). The ﬁrst 500 base pairs on the 50 end of the 16S
rRNA gene were ampliﬁed and sequenced using MicroSeq 500 16S
rDNA bacterial identiﬁcation PCR and sequencing kits (Applied
Biosystems, Foster City, CA, USA). The sequencing product was
analyzed on a 3130 Genetic Analyzer (Applied Biosystems)
according to the manufacturer’s instructions. The sequences
of the blood and tissue isolates were identical. The partial 16S
rRNA sequence of the blood isolate was deposited in GenBank
(accession number KP888634). Nucleotide BLAST searches (http://
blast.ncbi.nlm.nih.gov/Blast.cgi) of the isolate sequences showed
the following matches: B. pseudomallei NAU35A-3 (GenBank
accession number CP004378), 100% (440/440 bp); Burkholderia
mallei (NR_041725 and NR_074299), 99.8% (439/440 bp); B.
thailandensis (NZ_CM000438), 96.4% (407/422 bp); and B. cepacia
(NZ_KI421535 and NZ_KI421536), 95.9%. An antibiotic suscepti-
bility test was performed using the AST-N225 card (bioMe´rieux,
Inc.). The isolates were susceptible to ceftazidime (minimal
inhibitory concentration, MIC = 4 mg/ml), imipenem (MIC
0.25 mg/ml), and trimethoprim/sulfamethoxazole (MIC
20 mg/ml).
On hospital day 8, magnetic resonance imaging (MRI) of the
brain was performed to evaluate its involvement. The MRI scans
showed multifocal embolic infarction of the frontal, occipital,temporal, and parietal lobes, thalamus, pons, and cerebellum. The
antibiotics were changed to meropenem (2 g every 8 h, intrave-
nously). On hospital day 15, aorto-bifemoral artery bypass surgery
was performed to remove the remaining mycotic aneurysm in the
abdominal aorta. On hospital day 22, leakage was not observed
from the anastomosis sites or the remnant mycotic aneurysms,
visualized by CT angiography. After 35 days of intensive treatment
with meropenem, the patient received trimethoprim/sulfameth-
oxazole 800/160 mg per day for 1 week, but acute kidney injury
occurred. The antibiotics were changed to oral doxycycline
(100 mg twice per day) and continued for 5 months. No recurrence
or leakage was observed in the follow-up CT angiography.
3. Discussion
Mycotic aneurysm is a rare infectious disease with a poor
prognosis. The mortality rate is as high as 44%, even with surgical
and antimicrobial therapy. Common causative agents are Staphy-
lococcus aureus, Streptococcus species, and Salmonella species.3
Mycotic aneurysm due to B. pseudomallei is rare, but it was found to
be the most common causative agent (42.5%) in one study in
northeastern Thailand.3 Initially, B. pseudomallei was not consid-
ered, because melioidosis is rare in Korea. However, melioidosis
should be included in the differential diagnosis for mycotic
aneurysm in a patient with a history of travel to an endemic area.
The gold standard test for melioidosis is culturing B. pseudo-
mallei from the blood or infected tissue. B. pseudomallei grows
readily in blood culture media.1 In this case, Gram staining of the
colonies showed the typical features of B. pseudomallei.
Three different species of Burkholderia were identiﬁed in the
blood and tissue isolates using VITEK 2 and MALDI-TOF MS. B.
pseudomallei is often identiﬁed as other Burkholderia species using
commercial automated isolation systems.1 Using the VITEK
2 system, B. pseudomallei was identiﬁed with low accuracy
(69%) and misidentiﬁed as B. cepacia in 16% of samples.4 Recently,
MALDI-TOF MS has become more commonly used for the
identiﬁcation of bacteria as it is faster, but it can produce
misidentiﬁcations, as seen with B. pseudomallei.1 B. cepacia and
B. thailandensis are included in the MALDI Biotyper Reference
Library (Bruker Daltonics, version 3.3.1.2, 4612 entries). However,
B. pseudomallei and B. mallei are not included. They have been
added to the Bruker Security-Relevant (SR) Library, but one study
has shown that it cannot differentiate between the two.5 This is
also not available in Korea. The 16S rRNA sequences of B.
pseudomallei and B. mallei have a 1-bp difference at position 75,
which can be used to distinguish them according to a previous
report.6 These ﬁndings show that 16S rRNA sequencing is a useful
supplement to the automated diagnostic methods, VITEK 2 and
MALDI-TOF MS, for the identiﬁcation of B. pseudomallei.
In conclusion, melioidosis, a rare causative agent of mycotic
aneurysm with a high mortality rate, needs to be considered in
patients with a history of travel to an endemic area. It can be
misidentiﬁed as other Burkholderia species using VITEK 2 or
MALDI-TOF MS. Therefore, the typical features of the Gram
staining of colonies and 16S rRNA sequencing can be useful to
identify B. pseudomallei.
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